WEBVTT
Kind: captions
Language: en

00:00:06.259 --> 00:00:10.850
so certainly as an associate director

00:00:10.850 --> 00:00:10.860
so certainly as an associate director
 

00:00:10.860 --> 00:00:13.390
so certainly as an associate director
clinical development I helped to develop

00:00:13.390 --> 00:00:13.400
clinical development I helped to develop
 

00:00:13.400 --> 00:00:17.870
clinical development I helped to develop
drugs medicines that are important to to

00:00:17.870 --> 00:00:17.880
drugs medicines that are important to to
 

00:00:17.880 --> 00:00:20.529
drugs medicines that are important to to
the community the global community I

00:00:20.529 --> 00:00:20.539
the community the global community I
 

00:00:20.539 --> 00:00:24.290
the community the global community I
manage large trials what we call phase

00:00:24.290 --> 00:00:24.300
manage large trials what we call phase
 

00:00:24.300 --> 00:00:28.400
manage large trials what we call phase
three trials in essentially the medical

00:00:28.400 --> 00:00:28.410
three trials in essentially the medical
 

00:00:28.410 --> 00:00:30.410
three trials in essentially the medical
managing and monitoring of these studies

00:00:30.410 --> 00:00:30.420
managing and monitoring of these studies
 

00:00:30.420 --> 00:00:33.920
managing and monitoring of these studies
I and several other clinicians are

00:00:33.920 --> 00:00:33.930
I and several other clinicians are
 

00:00:33.930 --> 00:00:36.799
I and several other clinicians are
responsible for and we develop

00:00:36.799 --> 00:00:36.809
responsible for and we develop
 

00:00:36.809 --> 00:00:39.920
responsible for and we develop
strategies and on how to you know

00:00:39.920 --> 00:00:39.930
strategies and on how to you know
 

00:00:39.930 --> 00:00:44.150
strategies and on how to you know
improve some of our drugs or strategies

00:00:44.150 --> 00:00:44.160
improve some of our drugs or strategies
 

00:00:44.160 --> 00:00:50.080
improve some of our drugs or strategies
on how to manage new trials you know and

00:00:50.080 --> 00:00:50.090
on how to manage new trials you know and
 

00:00:50.090 --> 00:00:53.180
on how to manage new trials you know and
so that we can have these medicines

00:00:53.180 --> 00:00:53.190
so that we can have these medicines
 

00:00:53.190 --> 00:00:56.240
so that we can have these medicines
available to the community to the people

00:00:56.240 --> 00:00:56.250
available to the community to the people
 

00:00:56.250 --> 00:01:00.040
available to the community to the people
of patients that need so that definition

00:01:00.040 --> 00:01:00.050
of patients that need so that definition
 

00:01:00.050 --> 00:01:04.490
of patients that need so that definition
essentially what I do here advisor but

00:01:04.490 --> 00:01:04.500
essentially what I do here advisor but
 

00:01:04.500 --> 00:01:07.880
essentially what I do here advisor but
you know I almost cannot separate what I

00:01:07.880 --> 00:01:07.890
you know I almost cannot separate what I
 

00:01:07.890 --> 00:01:10.969
you know I almost cannot separate what I
do also from the philanthropy slide

00:01:10.969 --> 00:01:10.979
do also from the philanthropy slide
 

00:01:10.979 --> 00:01:14.330
do also from the philanthropy slide
because it's also an extension of my

00:01:14.330 --> 00:01:14.340
because it's also an extension of my
 

00:01:14.340 --> 00:01:18.170
because it's also an extension of my
work here in philanthropy you know I you

00:01:18.170 --> 00:01:18.180
work here in philanthropy you know I you
 

00:01:18.180 --> 00:01:20.899
work here in philanthropy you know I you
know amongst with with the rest of my

00:01:20.899 --> 00:01:20.909
know amongst with with the rest of my
 

00:01:20.909 --> 00:01:24.109
know amongst with with the rest of my
team you know help make these medicines

00:01:24.109 --> 00:01:24.119
team you know help make these medicines
 

00:01:24.119 --> 00:01:28.910
team you know help make these medicines
available to people that need it and not

00:01:28.910 --> 00:01:28.920
available to people that need it and not
 

00:01:28.920 --> 00:01:31.160
available to people that need it and not
just advisor but all the companies you

00:01:31.160 --> 00:01:31.170
just advisor but all the companies you
 

00:01:31.170 --> 00:01:34.420
just advisor but all the companies you
know I'm giving us their products to

00:01:34.420 --> 00:01:34.430
know I'm giving us their products to
 

00:01:34.430 --> 00:01:37.700
know I'm giving us their products to
distribute to communities that have need

00:01:37.700 --> 00:01:37.710
distribute to communities that have need
 

00:01:37.710 --> 00:01:40.460
distribute to communities that have need
for it so you know one way you know in

00:01:40.460 --> 00:01:40.470
for it so you know one way you know in
 

00:01:40.470 --> 00:01:42.710
for it so you know one way you know in
one job and helping develop these

00:01:42.710 --> 00:01:42.720
one job and helping develop these
 

00:01:42.720 --> 00:01:45.050
one job and helping develop these
medicines and then in the other job you

00:01:45.050 --> 00:01:45.060
medicines and then in the other job you
 

00:01:45.060 --> 00:01:47.389
medicines and then in the other job you
know I'm helping to provide these

00:01:47.389 --> 00:01:47.399
know I'm helping to provide these
 

00:01:47.399 --> 00:01:49.760
know I'm helping to provide these
medicines that we've developed to the

00:01:49.760 --> 00:01:49.770
medicines that we've developed to the
 

00:01:49.770 --> 00:01:52.160
medicines that we've developed to the
community so it's it's a win-win and and

00:01:52.160 --> 00:01:52.170
community so it's it's a win-win and and
 

00:01:52.170 --> 00:01:58.050
community so it's it's a win-win and and
I enjoy it

00:01:58.050 --> 00:01:58.060
 

00:01:58.060 --> 00:02:00.119
you

